[ Back to EurekAlert! ]

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute

Geoff Shapiro, Dana-Farber Cancer Institute

Caption: Geoffrey Shapiro, M.D., and colleagues at Dana-Farber Cancer Institute have demonstrated a molecular strategy they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs.

Credit: Sam Ogden

Usage Restrictions: None

Related news release: Blocking molecular target could make more cancers treatable with PARP inhibitors


[ Back to EurekAlert! ]